Evidence map›Paper›PMID 25460864›Full record

ArticleHeart rhythm2015

Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

David R Van Wagoner, Jonathan P Piccini, Christine M Albert, Mark E Anderson, Emelia J Benjamin, Bianca Brundel, Robert M Califf, Hugh Calkins, Peng-Sheng Chen, Nipavan Chiamvimonvat and 20 more

Abstract readConference Proceedings
In one paragraph

Article in Heart rhythm, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2017
    Guideline
  3. Guideline
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Impact of Sorbs2 dysfunction on cardiovascular diseases.Biochimica et biophysica acta. Molecular basis of disease · 2025
    Review
  11. Article
  12. Dual effects of the small-conductance CaAmerican journal of physiology. Heart and circulatory physiology · 2023
    Article
  13. Mortality in atrial fibrillation. Is it changing?Trends in cardiovascular medicine · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

David R Van WagonerCleveland Clinic Lerner College of Medicine of Case Western Research University. Electronic address: vanwagd@ccf.org.
Jonathan P PicciniDuke University Medical Center, Duke Clinical Research Institute.
Christine M AlbertBrigham and Women's Hospital and Harvard Medical School.
Mark E AndersonJohns Hopkins University School of Medicine.
Emelia J BenjaminBoston University Schools of Medicine & Public Health.
Bianca BrundelUniversity Medical Center Groningen.
Robert M CaliffDuke Translational Medicine Institute.
Hugh CalkinsJohns Hopkins University School of Medicine.
Peng-Sheng ChenKrannert Institute of Cardiology, Indiana University School of Medicine.
Nipavan ChiamvimonvatUniversity of California, Davis and the Department of Veterans Affairs, Northern California Health Care System.
Dawood DarbarVanderbilt University Medical Center.
Lee L EckhardtUniversity of Wisconsin-Madison.
Patrick T EllinorMassachusetts General Hospital, Broad Institute, and Harvard Medical School.
Derek V ExnerLibin Cardiovascular Institute of Alberta, University of Calgary.
Richard I FogelSt.Vincent Medical Group.
Anne M GillisLibin Cardiovascular Institute of Alberta, University of Calgary.
Jeff HealeyHamilton Health Sciences, McMaster University.
Stefan H HohnloserJ.W. Goethe University, Frankfurt, Germany.
Hooman KamelWeill Cornell Medical College.
David A LathropNational Heart, Lung, and Blood Institute, National Institutes of Health.
Gregory Y H LipUniversity of Birmingham, United Kingdom, and Aalborg University, Denmark.
Reena MehraCleveland Clinic Lerner College of Medicine of Case Western Research University.
Sanjiv M NarayanStanford University.
Jeffrey OlginUniversity of California San Francisco.
Douglas PackerMayo Clinic.
Nicholas S PetersImperial College & Imperial NHS Trust, London.
Dan M RodenVanderbilt University School of Medicine.
Heather M RossArizona State University.
Robert SheldonLibin Cardiovascular Institute of Alberta, University of Calgary.
Xander H T WehrensBaylor College of Medicine.

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
The Dynamics of Human Atrial FibrillationR01HL083359 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sanjiv M Narayan · 2008 to 2026
$7.9M
Ryanodine receptor regulation in post-operative atrial fibrillationR01HL089598 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2007 to 2022
$6.5M
Institutional Clinical and Translational Science AwardKL2TR000428 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$6.2M
Functional Genomics of Atrial Fibrillation in Human AtriaR01HL111314 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BARNARD, JOHN, CHUNG, MINA KAY · 2012 to 2019
$6.1M
The VITAL Rhythm StudyR01HL116690 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ALBERT, CHRISTINE M · 2013 to 2020
$3.5M
Arrhythmia Mechanisms from Inherited and Acquired Caveolin3 Dysregulation of IK1R01HL128598 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI ECKHARDT, LEE LOCHBAUM · 2015 to 2019
$1.9M
The Maintenance of Human Atrial FibrillationK24HL103800 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NARAYAN, SANJIV M · 2010 to 2019
$1.9M
Atrial Fibrillation Precursors May Be Novel Stroke Risk FactorsK23NS082367 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KAMEL, HOOMAN · 2013 to 2017
$937k
Regulation of ion channels in the heartI01BX000576 · VA · VA NORTHERN CALIFORNIA HEALTH CARE SYS · PI CHIAMVIMONVAT, NIPAVAN · 2009 to 2019
–
BLRD VA I01 BX000576British Heart Foundation RG/10/11/28457NCATS NIH HHS KL2 TR000428NCATS NIH HHS UL1 TR000427NHLBI NIH HHS K24 HL103800NHLBI NIH HHS R01 HL083359NHLBI NIH HHS R01 HL089598NHLBI NIH HHS R01 HL111314NHLBI NIH HHS R01 HL116690NHLBI NIH HHS R01 HL128598NINDS NIH HHS K23 NS082367
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Arrhythmia AgentsAtrial FibrillationBiomedical ResearchElectric CountershockHumansNeeds AssessmentRisk FactorsAnti-Arrhythmia Agents

Identifiers

PMID25460864
PMCPMC4425127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.